Cv Sciences, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

OQB
James Michael Corroon Jr., a director of CV Sciences, Inc., acquired 500,000 stock options on February 18, 2025.
OQB
Joerg Grasser, CFO of CV Sciences, Inc., reports the acquisition of 2,350,000 employee stock options.
OQB
CV Sciences CEO Joseph Dowling reports the acquisition of 3,000,000 employee stock options with an exercise price of $0.0375, vesting monthly over three years from February 18, 2025.
OQB
Director William McCorkle reports acquisition of 500,000 stock options in CV Sciences, Inc.
OQB
Director William McCorkle acquired 500,000 stock options in CV Sciences, Inc. on June 20, 2024.
OQB
Director James Michael Corroon Jr. of CV Sciences, Inc. reports acquiring 500,000 stock options on June 20, 2024.
OQB
Joerg Grasser, CFO of CV Sciences, Inc., acquired 2,350,000 employee stock options on June 20, 2024, according to a Form 4 filing with the SEC.
OQB
CV Sciences CEO Joseph Dowling was granted 3,000,000 employee stock options on June 20, 2024, according to a Form 4 filing with the SEC.